Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1964 3
1975 1
1979 3
1982 1
1983 1
1986 1
1988 2
1989 1
1990 1
1991 4
1993 2
1994 3
1995 3
1996 1
1997 6
1998 8
1999 2
2000 7
2001 3
2002 6
2003 6
2004 8
2005 19
2006 16
2007 14
2008 21
2009 27
2010 27
2011 33
2012 28
2013 35
2014 32
2015 49
2016 51
2017 44
2018 56
2019 47
2020 80
2021 98
2022 87
2023 62
2024 69
2025 76
2026 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

970 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jang yp[Author] (122 results)?
Decoding and reconstructing disease relations between dry eye and depression: a multimodal investigation comprising meta-analysis, genetic pathways and Mendelian randomization.
Chang KJ, Wu HY, Chiang PH, Hsu YT, Weng PY, Yu TH, Li CY, Chen YH, Dai HJ, Tsai HY, Chang YJ, Wu YR, Yang YP, Li CT, Hsu CC, Chen SJ, Chen YC, Cheng CY, Hsieh AR, Chiou SH. Chang KJ, et al. Among authors: yang yp. J Adv Res. 2025 Mar;69:197-213. doi: 10.1016/j.jare.2024.03.015. Epub 2024 Mar 27. J Adv Res. 2025. PMID: 38548265 Free PMC article.
Versatile dopamine-functionalized hyaluronic acid-recombinant human collagen hydrogel promoting diabetic wound healing via inflammation control and vascularization tissue regeneration.
Wang Y, Zhang Y, Yang YP, Jin MY, Huang S, Zhuang ZM, Zhang T, Cao LL, Lin XY, Chen J, Du YZ, Chen J, Tan WQ. Wang Y, et al. Among authors: yang yp. Bioact Mater. 2024 Feb 14;35:330-345. doi: 10.1016/j.bioactmat.2024.02.010. eCollection 2024 May. Bioact Mater. 2024. PMID: 38379700 Free PMC article.
Inhibition of oxidative stress-induced epithelial-mesenchymal transition in retinal pigment epithelial cells of age-related macular degeneration model by suppressing ERK activation.
Yang YC, Chien Y, Yarmishyn AA, Lim LY, Tsai HY, Kuo WC, Tsai PH, Yang SH, Hong SI, Chen SJ, Hwang DK, Yang YP, Chiou SH. Yang YC, et al. Among authors: yang yp. J Adv Res. 2024 Jun;60:141-157. doi: 10.1016/j.jare.2023.06.004. Epub 2023 Jun 15. J Adv Res. 2024. PMID: 37328058 Free PMC article.
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial.
Zhao ZR, Liu SL, Zhou T, Chen G, Long H, Su XD, Zhang X, Fu JH, Lin P, Zhang LJ, Rong TH, Wu JD, Li ZC, Su HL, Chen JY, Yang YP, Lin YB, Xi M, Yang H. Zhao ZR, et al. Among authors: yang yp. Lancet Respir Med. 2024 Dec;12(12):988-996. doi: 10.1016/S2213-2600(24)00215-7. Epub 2024 Sep 18. Lancet Respir Med. 2024. PMID: 39305910 Clinical Trial.
Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation.
Xu A, Liu M, Huang MF, Zhang Y, Hu R, Gingold JA, Liu Y, Zhu D, Chien CS, Wang WC, Liao Z, Yuan F, Hsu CW, Tu J, Yu Y, Rosen T, Xiong F, Jia P, Yang YP, Bazer DA, Chen YW, Li W, Huff CD, Zhu JJ, Aguilo F, Chiou SH, Boles NC, Lai CC, Hung MC, Zhao Z, Van Nostrand EL, Zhao R, Lee DF. Xu A, et al. Among authors: yang yp. Nat Commun. 2023 Mar 27;14(1):1694. doi: 10.1038/s41467-023-37398-9. Nat Commun. 2023. PMID: 36973285 Free PMC article.
Hybprinting for musculoskeletal tissue engineering.
Li J, Kim C, Pan CC, Babian A, Lui E, Young JL, Moeinzadeh S, Kim S, Yang YP. Li J, et al. Among authors: yang yp. iScience. 2022 Apr 8;25(5):104229. doi: 10.1016/j.isci.2022.104229. eCollection 2022 May 20. iScience. 2022. PMID: 35494239 Free PMC article. Review.
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials.
Hong SD, Wang YS, Zhao HY, Zhao YY, Wang QM, Ma YX, Li YS, Huang Y, Yang YP, Fu ZM, Chen LK, Zhou F, Yang J, Li XY, Hou X, Zhou NN, Sun LH, Zhang GF, Cui JW, Wu L, Chen G, Zhang YX, Wang HY, Lv DQ, Shi JH, Jiang B, Li C, Li XL, Tang KJ, Yu Y, Ji YH, He ZY, Zhu Y, Zhu H, Xiao S, Zhou CC, Zhang L, Fang WF. Hong SD, et al. Among authors: yang yp. Ann Oncol. 2026 Jun;37(6):813-824. doi: 10.1016/j.annonc.2026.01.009. Epub 2026 Jan 27. Ann Oncol. 2026. PMID: 41611210 Clinical Trial.
970 results